RxDoctor Payments DataLook up a doctor →

Marcus Smith, MD

Interventional Cardiology · Oklahoma City, OKNPI 1578769055

Payments from drug & device makers

$67,295in general payments, 2019–2025

Across 581 payments — averaging $115.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$38K
  • Lilly USA, LLC$19K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$2K
  • Johnson & Johnson$1K
  • Amarin Pharma, Inc.$726
  • E.r. Squibb & Sons, L.L.C.$663
  • plus $5K from 38 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boehringer Ingelheim36$37,966
Lilly USA, LLC23$19,425
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)101$1,818
Johnson & Johnson93$1,280
Amarin Pharma, Inc.59$726
E.r. Squibb & Sons, L.L.C.33$663
Abbott15$596
Amgen24$484
Novo Nordisk24$466
AstraZeneca17$400
Merck33$374
Esperion Therapeutics, Inc.13$354
Sanofi-aventis U.S. LLC16$253
Terumo Medical Corporation1$250
Astellas Pharma US Inc6$201
Novartis10$189
Philips North America LLC2$188
Boston Scientific12$184
Cvrx, Inc.3$175
Kestra Medical Technology Services, Inc.7$162
Kowa Pharmaceuticals America, Inc.10$150
Impulse Dynamics (USA) Inc.1$125
Pfizer7$119
Medtronic(2 entities)4$109
Veryan Medical Incorporated4$68
Actelion Pharmaceuticals US, Inc.3$58
Baxter Healthcare1$58
Silk Road Medical, Inc.1$58
Lexicon Pharmaceuticals, Inc.2$50
Lundbeck LLC3$47
Lantheus Medical Imaging, Inc.2$37
GE HealthCare1$33
Irhythm Technologies, Inc.2$31
Regeneron Healthcare Solutions, Inc.2$29
Kerecis Limited1$25
Endologix LLC1$24
Cordis US CORP.1$23
Angiodynamics, Inc.1$19
Alnylam Pharmaceuticals Inc.1$18
Cardiva Medical, Inc.1$16
ZOLL Circulation Inc1$14
Gilead1$12
Bardy Diagnostics, Inc.1$11
Althera Pharmaceuticals LLC1$6

How this compares

$67,295 in reported general payments places this provider in the 80th percentile of 110 interventional cardiology providers in Oklahoma.

See all interventional cardiology providers in Oklahoma →

Medicare billing

Part B allowed, 2024
$1,923,204
Medicare patients
1,681
Services billed
9,900

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Oklahoma City

See the full list for Oklahoma →

Where these figures come from

Is this you, or does something look wrong? →